Improving adeno-associated vector yield in high density insect cell cultures

被引:28
|
作者
Mena, Jimmy A. [1 ]
Aucoin, Marc G. [2 ]
Montes, Johnny [1 ]
Chahal, Parminder S. [1 ]
Kamen, Amine A. [1 ]
机构
[1] Natl Res Council Canada, Anim Cell Technol Grp, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada
[2] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada
来源
JOURNAL OF GENE MEDICINE | 2010年 / 12卷 / 02期
关键词
adeno-associated virus (AAV) vectors; baculovirus; fed-batch; gene therapy; high cell density; insect cells; BACULOVIRUS EXPRESSION SYSTEM; LARGE-SCALE PRODUCTION; FED-BATCH CULTURE; GENE-TRANSFER; SUSPENSION-CULTURE; VIRAL VECTORS; SF-9; CELLS; INFECTION; VIRUS; AAV;
D O I
10.1002/jgm.1420
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Recombinant adeno-associated virus (rAAV) are the most promising vectors for gene therapy. However, large-scale rAAV production remains a challenge for the translation of rAAV-based therapeutic strategies to the clinic. The baculovirus expression vector system (BEVS) has been engineered to produce high rAAV titers in serum-free suspension cultures of insect cells. Methods The typical approach of rAAV production in BEVS has been based on a synchronous infection with three baculoviruses at high multiplicity of infection (MOI) [>3 plaque forming units (pfu)/cell]. An alternative approach is to co-infect at low MOI (0.1 pfu/cell). Both strategies (high and low MOI) were compared at a cell density of 1.0 x 10(6) cells/ml in shake-flask experiments. To increase the rAAV titer, a low MOI combined with an initial cell density at infection of 5.0 x 10(6) cells/ml, in fed-batch mode, was evaluated. Subsequently, the production strategy was validated in 3-1 bioreactor runs. Results An increase of 210% in the rAAV titer (4.7 x 10(11) enhanced transduction units/l) was observed when using low MOI, an effect primarily caused by the increase in cell density. The fed-batch approach resulted in a seven-fold increase of rAAV yield. Controlled operations in bioreactor contributed to further increase the rAAV yield (2.8 x 10(14) vector genomes/l) by 25% in comparison to the shake flask results. Conclusions This high yield production process using low MOIs and a feeding strategy successfully addresses several limitations of current rAAV production in insect cells and contributes to position the BEVS system as one of the most efficient for large-scale manufacturing of rAAV vectors. Copyright (C) 2010 John Wiley & Sons, Ltd. The copyright in Jimmy A. Mena's, Johnny Montes', Parminder S. Chahal's and Amine A. Kamen's contributions belongs to the Crown in right of Canada and such copyright material is reproduced with the permission of the Research Council of Canada.
引用
收藏
页码:157 / 167
页数:11
相关论文
共 50 条
  • [41] Proteome profiling and vector yield optimization in a recombinant adeno-associated virus-producing yeast model
    Aponte-Ubillus, Juan Jose
    Barajas, Daniel
    Sterling, Harry
    Aghajanirefah, Ali
    Bardliving, Cameron
    Peltier, Joseph
    Shamlou, Parviz
    Roy, Mimi
    Gold, Daniel
    MICROBIOLOGYOPEN, 2020, 9 (12):
  • [42] hEPO transfer and expression by a recombinant adeno-associated virus vector
    Wu, ZJ
    Wu, XB
    Wang, H
    Lu, B
    Dong, XY
    Hou, YD
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2002, 34 (02) : 176 - 180
  • [43] Adeno-associated viral vector gene transfer into leptomeningeal xenografts
    Rosenfeld, MR
    Bergman, I
    Schramm, L
    Griffin, JA
    Kaplitt, MG
    Meneses, PI
    JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (02) : 139 - 144
  • [44] Efficient transduction of human neurons with an adeno-associated virus vector
    Du, B
    Wu, P
    BoldtHoule, DM
    Terwilliger, EF
    GENE THERAPY, 1996, 3 (03) : 254 - 261
  • [45] Adeno-Associated Virus Vector Mobilization, Risk Versus Reality
    Song, Liujiang
    Samulski, R. Jude
    Hirsch, Matthew L.
    HUMAN GENE THERAPY, 2020, 31 (19-20) : 1054 - 1067
  • [46] Adeno-associated viral vector gene transfer into leptomeningeal xenografts
    Myrna R. Rosenfeld
    Ira Bergman
    Laura Schramm
    Judith A. Griffin
    Michael G. Kaplitt
    Patricio I. Meneses
    Journal of Neuro-Oncology, 1997, 34 : 139 - 144
  • [47] Adeno-Associated Vector Discovery Platform for Inner Ear Disorders
    Giese, Arnaud P. J.
    Vidal, Patrice
    Broussy, Audrey
    Olivier, Guillaume
    Dadak, Selma
    Descossy, Vincent
    Van Ba, Christophe Tran
    Dos Reis, Julie Duron
    Liaudet, Pauline
    Riviere, Anais
    Farsad, Hanae
    Desire, Laurent
    Yang, Nora
    MOLECULAR THERAPY, 2022, 30 (04) : 440 - 441
  • [48] Adeno-associated virus vector as a platform for gene therapy delivery
    Dan Wang
    Phillip W. L. Tai
    Guangping Gao
    Nature Reviews Drug Discovery, 2019, 18 : 358 - 378
  • [49] Adeno-associated virus: from defective virus to effective vector
    Goncalves, Manuel A. F. V.
    VIROLOGY JOURNAL, 2005, 2 (1)
  • [50] Adeno-associated virus: from defective virus to effective vector
    Manuel AFV Gonçalves
    Virology Journal, 2